Full Press Release Details
fda approves first in class evkeeza evinacumab dgnb for young children with ultra rare form of high cholesterol.
REGN
fda approves first in class evkeeza evinacumab dgnb for young children with ultra rare form of high cholesterol
Key Takeaway: fda approves first in class evkeeza evinacumab dgnb for young children with ultra rare form of high cholesterol